Document is current
Any future updates will be listed below
-
Authors
Ogwel, Billy
Mzazi, Vincent H.
Awuor, Alex O.
Okonji, Caleb
Anyango, Raphael O.
Oreso, Caren
Ochieng, John B.
Munga, Stephen
Nasrin, Dilruba
Tickell, Kirkby D.
Pavlinac, Patricia B.
Kotloff, Karen L.
Omore, Richard
- License Information
-
More Information
Article History
Received: 8 March 2024
Accepted: 3 January 2025
First Online: 15 January 2025
Declarations
:
: VIDA protocol was approved by the Institutional Review Board of the University of Maryland School of Medicine, Baltimore, MD, USA (UMB Protocol #: HM-HP-00062472) and the Kenya Medical Research Institute (KEMRI) Scientific and Ethical Review Unit (SERU) (SERU#2996). The EFGH protocol was approved by the KEMRI SERU (SERU#4362). Written informed consent was sought from caregivers in both studies before initiation of study procedures. Additionally, ethical approval for undertaking the current study was sought from the health research ethics committee of the University of South Africa, College of Agricultural Sciences (2023/CAES_HREC/2192).
: Not applicable.
: The authors declare no competing interests.
